Previous 10 | Next 10 |
AIkido Pharma (AIKI) shares up ~62% premarket after it announces execution of a Patent License Agreement for technology that covers the use of psychedelic compound psilocybin for cancer applications.The technology is covered by four patent applications already on file with the ...
AIkido Pharma Inc. Executes Licensing Agreement for Psilocybin for Cancer Applications PR Newswire NEW YORK , Jan. 6, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company executed a Patent Licens...
4 Penny Stocks Trading Higher Before The New Year; Are They Still A Buy? Wednesday, December 30th was an overall good day for penny stocks . As we turn the corner on 2020, investors are still looking for last-minute opportunities. And with a new year ahead, we could be in store for ...
Can These 5 Penny Stocks Continue to Rally? Throughout the month of December, investors have seen a lot of positive sentiment with penny stocks . While trading these stocks has changed in 2020, the majority of the factors remain largely the same. This includes understanding the fund...
AIkido Pharma Announces Publication of Artificial Intelligence-Machine Learning Sponsored Research Program for Pancreatic Cancer NEW YORK , Dec. 9, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the publication of ...
AIkido Pharma Inc. Announces Results of 2020 Annual Stockholder Meeting All stockholder proposals were approved other than the authority for a reverse stock spilt The meeting was adjourned to allow more time to collect votes on the reverse stock split The Company urges s...
AIkido Pharma Inc. Announces Publication of Favorable Peer Reviewed Study of Newly Licensed Antiviral Compounds Lead compounds have anti-coronavirus activity, including against SARS-CoV and SARS-CoV2 PR Newswire NEW YORK, Nov. 13, 2020 NEW YORK , Nov. 13, 2...
AIkido Pharma Inc. Provides Update on Its Next-Generation Chemotherapeutic Treatment DHA-dFdC Synthesis of Critical Chemical Intermediate for Drug Confirmed PR Newswire NEW YORK, Oct. 28, 2020 NEW YORK , Oct. 28, 2020 /PRNewswire/ -- AIkido Pharma In...
NEW YORK , Sept. 18, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) today announced that its work with research partner, Cogia BioTech LTD ( www.cogia.de ), has delivered several key updates on efforts to accelerate the study of PDA (Pancreatic Ductal Adenocarcinoma) treatmen...
Point Roberts, WA and Delta, BC - September 18, 2020 (Investorideas.com Newswire) Investorideas.com , a global news source and leading retail investor resource announces its weekly roundup of stocks added to its free global stock directories; biotech, gaming and eSport. The newest biotech com...
News, Short Squeeze, Breakout and More Instantly...
AIkido Pharma Inc. Company Name:
AIKI Stock Symbol:
NASDAQ Market:
AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) PR Newswire NEW YORK , Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (the "Company") today announced that it has changed its name from AI...
AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes PR Newswire Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI NEW YORK , Nov. 28, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (...
AIkido Share Repurchase Continues PR Newswire NEW YORK , Oct. 6, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company's share repurchase program (the "Share Repurchase Program") authori...